NCT04725994
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04725994
Title Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination with XELOX or Irinotecan in Patients with Advanced Gastric Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Idience Co., Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
USC Norris Comp. Cancer Ctr Hospital Los Angeles California 90033 United States Details
Hematology Oncology Clinic Baton Rouge / Sarah Cannon Baton Rouge Louisiana 70809 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Astera Cancer Care East Brunswick New Jersey 08816 United States Details
Beijing Cancer Hospital Beijing China Details
The Sixth Affiliated Hospital of Sun Yat-Sen University Guangzhou China Details
Shanghai East Hospital Shanghai China Details
Jeonbuk National University Hospital Jeonju Jeollabuk-do South Korea Details
Dong-A University Hospital Busan 49201 South Korea Details
Seoul National University Bundang Hospital Seongnam South Korea Details
Korea University Anam Hospital Seoul 02841 South Korea Details
Korea University Guro Hospital Seoul 08308 South Korea Details
Asan Medical Center Seoul South Korea Details
Samsung Medical Center Seoul South Korea Details
Seoul National University Hospital Seoul South Korea Details
Severance Hospital - Yonsei Cancer Center Seoul South Korea Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field